Aaron Cowen’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,245
Closed -$4.75M 104
2023
Q4
$4.75M Hold
35,245
0.21% 54
2023
Q3
$4.77M Buy
35,245
+17,300
+96% +$2.36M 0.26% 53
2023
Q2
$2.57M Hold
17,945
0.14% 68
2023
Q1
$2.49M Buy
17,945
+10,100
+129% +$1.36M 0.11% 66
2022
Q4
$1.06M Buy
+7,845
New +$984K 0.04% 70

Other funds holding AZN

Aaron Cowen's AZN Position: Q1 2024 in Review

Aaron Cowen sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 35,245 shares — an estimated $4.75M sold.

Aaron Cowen first reported a position in AZN in Q4 2022 and held it in 5 quarters. The position peaked at $4.77M in Q3 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Aaron Cowen reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Aaron Cowen sold 35,245 AstraZeneca shares in Q1 2024, an estimated $4.75M.
  • Aaron Cowen first reported a position in AstraZeneca in Q4 2022 and held it in 5 quarters.
  • Aaron Cowen's AstraZeneca position peaked at $4.77M in Q3 2023.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Suvretta Capital Management's 13F filing for Q1 2024, filed 15 May 2024.